Regenovo
Hangzhou · Founded 2013
About Regenovo
Regenovo offers a complete 3D printing technology for the biomedical field. Regenovo builds a digital medical chain from medical information to medical product customization and has a dual-core industrial complex of"bio-3D printing and biomaterials. Regenovo has a complete technical system ranging from bio-3D printing equipment, biomaterials, and devices, to tissue organoid research and development and production, and offers systematic products and services for scientific research, drug development, regenerative medicine, and personalized medicine.
Company Facts
- Founded: 2013
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2018)
- Website: http://www.regenovo.com/
- Phone: +86 0571-85788536
Industries & Categories
3D Printing, 3D Technology, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/regenovo-56685 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.